Construction of an environmental exposure unit and investigation of the effects of cetirizine hydrochloride on symptoms of cedar pollinosis in Japan

Journal of Investigational Allergology and Clinical Immunology

Volumn 17, Issue 3, 2007, Pages 173-181

  Enomoto, Tadao ^a   Ide, T ^b   Ogino, S ^c  

^a SUWA RED CROSS HOSPITAL   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Cetirizine; Environmental exposure unit; Japanese cedar pollinosis; Second generation antihistamine

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; PETROLATUM; PLACEBO; POLLEN ANTIGEN;

ADULT; ALLERGY TEST; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL EXPOSURE UNIT; ERROR; FEMALE; HUMAN; MALE; NOSE CONGESTION; OUTCOME ASSESSMENT; POLLEN ALLERGY; PSYCHOLOGIC TEST; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SNEEZING; SOMNOLENCE; UCHIDA KRAEPELIN TEST;

ADULT; CEDRUS; CETIRIZINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENVIRONMENTAL EXPOSURE; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOLOGIC TESTS; JAPAN; MALE; MIDDLE AGED; POLLEN;

EID: 34249999131     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Baba K, Konno A, Takenaka H. [Allergic Rhinitis Therapeutic Guidelines Preparation Committee: Allergic rhinitis therapeutic guidelines: perennial rhinitis and hay-fever, 2005 edition, 5th revision (in Japanese)] Tokyo: Life Science; 2005.
2. Meltzer EO, Weiler JM, Widlitz MD. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J Allergy Clin Immunol. 1996;97:617-26.
3. Hyo S, Fujieda S, Kawada R, Kitazawa S, Takenaka H. The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen. Ann Allergy Asthma Immunol. 2005;94:457-64.
4. Asaga H, Yoshida H, Baba K. [Clinical efficacy of Ebastin in the treatment of cedar pollinosis in an outdoor comparative study (in Japanese)] Arerugi. 2002;51:357-63.
5. Horak F, Stubner P, Zieglmayer R, Kavina A, De Vos C, Burtin B, Donnelly F. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis. Int Arch Allergy Immunol. 2001;125:73-9.
6. Day JH, Briscoe MP, Clark RH, Ellis AK, Gervais P. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis. Ann Allergy Asthma Immunol. 1997;79:163-72.
7. Berkowitz RB, Woodworth GG, Lutz C, Weiler K, Weiler J, Moss M, Meeves S. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit. Ann Allergy Asthma Immunol. 2002;89:38-45.
8. Krug N, Loedding H, Hohlfeld JM, Larbig M, Buckendahl A, Badorrek P, Geldmacher H, Behnke W, Dunkhorst W, Windt H, Luettig B, Koch W. Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis. Clin Exp Allergy. 2003;33:1667-74.
9. Day JH, Horak F, Briscoe MP, Canonica GW, Fineman SM, Krug N, Leynadier F, Lieberman P, Quirce S, Tanenaka H, Van Cauwenberge P. The role of allergen challenge chambers in the evaluation of anti-allergic medication: an international consensus paper. Clinical & Experimental Allergy Reviews. 2006;6:31-59.
10. Ronborg SM, Mosbech H, Johnsen CR, Poulsen LK. Exposure chamber for allergen challenge. The development and validation of a new concept. Allergy. 1996;51:82-8.
11. Kuraishi S, Kato M, Tsujioka B. Development of the "Uchida-Kraepelin psychodiagnostic test" in Japan. Psychologia. 1957;1:104-9.
12. Murasaki M, Miura S, Ishigooka J, Ishii Y, Takahashi A, Fukuyama Y. Phase I study of a new antianxiety drug, buspirone. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13:137-44.
13. Hyo S, Fujieda S, Kawada R, Kitazawa S, Takenaka H. The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen. Annals of allergy, asthma, and immunology. 2005;94:457-65
14. Day JH, Briscoe M, Widlitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol. 1998;101:638-45.
15. Oguchi K, Uchida E, Kobayashi S, Yasuhara H. Clinical pharmacological study of Veganin, a proprietary cold remedy: Evaluation of sleepiness with psychomotor performance tests. J Clin Ther Med. 1988;4:839-49.